Davis Asset Management L.P. bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 4,000 shares of the company’s stock, valued at approximately $514,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA in the 2nd quarter worth approximately $27,000. Bard Associates Inc. purchased a new position in Merck KGaA in the 2nd quarter valued at approximately $60,000. Kilter Group LLC purchased a new position in Merck KGaA in the 2nd quarter valued at approximately $62,000. Finally, Addison Advisors LLC acquired a new position in Merck KGaA during the second quarter worth $90,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Price Performance
Merck KGaA stock opened at $163.21 on Friday. The firm has a market capitalization of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The firm’s 50-day simple moving average is $162.62 and its 200 day simple moving average is $148.46. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
